❌

Reading view

There are new articles available, click to refresh the page.

Announcing Privacy Badger for Safari on macOS

Exciting news for Safari users: Privacy Badger is now available on Safari for macOS! You’ll need Safari version 26.5 or higher to use it.

Whether you want to protect yourself from data brokers or just don’t want Big Tech profiting off your browsing data, Privacy Badger is here to help. More than 4 million people already use EFF’s free tracker-blocking extension to take a stand against online surveillance. Safari users can now join them and EFF in the fight for a better web.  

Install Privacy Badger

Support the Fight Against Online Tracking

Safari support has been one of Privacy Badger’s most requested features for years. Thanks to recent improvements in Safari's extension support, we’ve finally made it happen for Safari version 26.5 and higher. Privacy Badger is now available on all major desktop browsers. And before you ask, yes, we will look into supporting Safari for iOS once we've ironed out any issues on macOS.

Why Install Privacy Badger on Safari? 

Most websites contain invisible tracking code that lets companies collect, share, and profit from your personal data. Some of those companies are data brokers that sell your information to anyone willing to pay. Creepy ads are just the tip of the iceberg when it comes to the harms of online tracking: Once your information enters the data broker ecosystem, it’s nearly impossible to know who buys it or what they’re doing with it. Privacy Badger blocks online trackers to prevent your browsing data from being used against you.  

Privacy Badger goes beyond Safari’s built-in privacy features to provide additional protection against online tracking. In its default browsing mode, Safari limits the information that trackers can access but still allows them to load. Privacy Badger blocks trackers from loading in the first place, preventing them from tracking you using techniques that bypass Safari’s protections. 

Privacy Badger works well by itself, and will continue to enhance your privacy when installed along side an ad blocker or with Safari’s Advanced settings to block trackers in all windows. Since Privacy Badger automatically learns to block trackers, Privacy Badger will block trackers that other tools don’t know about or choose not to block. 

For example, Privacy Badger blocks tracking from widgets like embedded tweets, comments sections, and video players. These widgets can share your data even if you never click on them. Privacy Badger prevents these trackers from loading and replaces them with click-to-activate placeholders. 

Beyond tracker blocking, Privacy Badger automatically sends the Global Privacy Control (GPC) signal to tell websites not to sell or share your personal information. The GPC signal is already legally binding in a growing number of states, including California, Colorado, New Jersey, and Connecticut.  

All these features (and more) work together to help keep your browsing activity private on Safari. 

Try It Out and Spread the Word 

If you use Safari on macOS, give Privacy Badger a try. You’ll install Privacy Badger through the App Store on your macOS device. Installing extensions is a little more complicated on Safari than other browsers, so follow Apple’s directions here if you’re having trouble.  

This is our first release of Privacy Badger for Safari, and we will keep improving it based on your feedback. If you run into any problems, let us know by emailing extension-devs@eff.org, or by opening an issue on GitHub. And if blocking harmful trackers causes issues on a website you visit, you can disable Privacy Badger for that specific site while keeping it enabled and protecting you everywhere else. You can also let us know about broken sites by using the “Report broken site” button found next to the “Disable for this site” button in Privacy Badger’s popup window. 

When you use Privacy Badger, you join EFF and millions of other users in the fight for a better web. Help spread the word by telling your friends and family who use Safari that they can use Privacy Badger too!  

Install Privacy Badger 

Support the Fight Against Online Tracking 

She Taught the Macintosh to Smile

The Macintosh didn’t always smile. Susan Kare gave it one — and with a handful of black pixels, helped transform the computer from an intimidating machine into something that felt human. More than 40 years later, we’re still speaking the visual language she helped create.

MyChart and a major hospital said I could opt out of sharing my health data. But they didn’t make it easy

My journey included a notary, a hospital that won’t honor its own policies and employees that gave me wrong information.

Illustration of a patient standing in the middle of a maze which spells out the words “opt out”; there are multiple signs pointing to different directions with written phrases like “call compliance,” “contact medical records,” “visit notary,” and “mail letter”
Illustration by Gabriel Hongsdusit, CalMatters

Dr. Shira Fischer, a physician who works in health policy in Boston, sought a speech pathologist for her child in 2022, when virtual appointments became the norm because of COVID-19. 

“I read their consent and they said they were going to record and use [our appointment] for training. And I said, no, my kid has a lisp. The last thing she wants is videos of her lisping to be used for training for who knows how long and who knows what database.” 

Fischer said the clinic wouldn’t change the consent, and wouldn’t proceed with the appointment if she didn’t sign it. Eventually, she found a different speech pathologist. “It ended up being better. But what is that, that they require you to allow them to record for their training?” 

Every day, doctor’s offices across the country tell patients that if they want to see the doctor, they must allow their health data to be accessible by tens of thousands of hospitals and clinics. Often, doctors give out overly broad consent forms, asking patients to agree to anything from hospitals using patient files for training doctors to using patient data for training AI.

Practically speaking, when a patient doesn’t agree, doctors can turn them away.

Other times, doctors’ offices tell patients they can opt-out of sharing their data later — by contacting an email address or mailing a physical letter — but in reality, opting out can be so difficult and confusing that it isn’t really a choice at all.

When I was pregnant with my child, I wondered why my gynecologists’ forms asked me to let another company, Phreesia, mine my health data for marketing. The authorization form was labeled “Required” even though it legally must be optional. I systematically opted out and kept my own records of this, but when I tried to confirm my opt-outs with Phreesia, it said I did consent. After 81 days of back and forth, Phreesia admitted I had never authorized them to use my data. But it continued to use the misleading “Required” label on the authorization form. Months later, after complaining to the U.S. Department of Health and Human Services, and an episode of “The Indicator from Planet Money” on NPR, Phreesia changed how it labeled its forms. I found the process galling, but it spurred my curiosity, and I’ve been researching how opt-outs work ever since.

In the last year, I registered as a patient at 25 clinics and hospitals across seven states and spent hundreds of hours reviewing consent forms, privacy policies and marketing forms to see whether I could actually opt out of sharing my data.

For one hospital in Ohio, it took me 26 steps, a notary, and a flight to Las Vegas to learn how to opt out of the hospital’s many uses of my patient records. Despite my best efforts, the hospital will not follow its own policy, which ostensibly allows patients to refuse to allow the hospital to take and own photos and recordings of them.


It started last January, when I sought a second opinion on a personal health issue with a specialist at University Hospitals in Westlake, Ohio. University Hospitals is a large, nonprofit hospital system that manages its electronic health records through MyChart, a widely used patient portal across the country. MyChart is made by Epic Systems, a healthcare software company in Verona, Wisconsin, that says it has over 305 million patient charts, coming from patients in every state and more than a dozen countries. 

As I prepared for my appointment, the hospital asked me to sign its registration forms and to sign up for MyChart. In the dense terms of service, I spot three different ways that as a patient, my data is about to be used, accessed or shared:

  1. The hospital will share my health data through Epic’s proprietary health information platform, Care Everywhere. 
  2. The hospital will share my data with CliniSync, an Ohio-based nonprofit health information exchange that facilitates the exchange of patients’ information, like lab results, across institutions. 
  3. The hospital will own any photos, audio, or video they take of me and may use them for any lawful purpose.

In each case, I’m told that I can opt-out or refuse, but the process felt like it was designed to keep me from doing so. Forms and websites lacked basic contact information; customer service didn’t respond; patients were required to find a notary, and hospital staff directly contradicted their own written policies and told me I wasn’t allowed to opt-out.

So I set out to see what it would truly take to say no to sharing my data, starting with Epic.

There’s no button to revoke authorization everywhere

Once a hospital makes a patient’s records available through Epic’s Care Everywhere, many clinicians who work with Epic across the country can pull up those records, with some exceptions. 

The most common way doctors use health exchanges is to get up to speed on a patient who is coming to see them. Sharing patient health records through exchanges has decreased duplicative tests on patients. It also allows emergency room doctors who have never seen a patient before to immediately get their health history and allergies, which can save a patient’s life, said Saurabh Rahurkar, a former assistant professor at Ohio State University College of Medicine.

Individual hospitals can also restrict which doctors can see a patient’s files, such as by physical distance, or by adding an extra confirmation step before doctors can see the files of patients who have received psychological services. 

“If you say to your new doctor, ‘Please go get my records at this place that’s 3,000 miles away,’ Care Everywhere can do that, but not if the system has the settings to only look for records within a 50-mile radius,” said Lucia Savage, former chief privacy officer at the federal health IT office. 

But there are clear reasons why some patients don’t want their data to show up in these searches, and hospital protections, if they exist at all, are not always effective.

For example, a patient who crosses state lines to seek an abortion treatment may not want her records to be searchable by her providers in her home state where that treatment is criminalized. 

“People who have had bad experiences with unauthorized access to their information and people who have sensitive health conditions and diagnoses for very good reasons, are just mistrusting of the healthcare system,” said Julia Adler-Milstein, a leading researcher in health IT policy and a professor of medicine at the University of California, San Francisco. “(They) don’t feel like the healthcare system has been a good steward of them and their information.” 

For example, researchers reviewing 1,138 breach cases found that almost 10% of patient health data breaches come from unauthorized access by health care employees who forward personally identifying information to personal accounts.

Nichole Sweeney, who was recently the chief privacy officer and general counsel at CRISP Shared Services, which provides technology infrastructure to support health exchanges in more than 10 states, said she often encounters providers snooping in patient records in her job as a privacy officer: “Somebody, a provider in an office, looks up an ex, and we find that because we have monitoring software, and I have to call them and tell them not to do that anymore. They get fired sometimes.”

Cason Schmit, a health law and policy professor at Texas A&M University, warned, “We’re at a place in time where data that are being collected to help people are now being used in ways that could actively and specifically harm them.” He pointed to how Immigration and Customs Enforcement has used health data for immigration enforcement. Schmit has written about the role of state policy in fostering health information exchange and its benefits to the public, such as tracking measles outbreaks.

In my attempt to opt out of Epic’s Care Everywhere, I first looked for a way to do it with MyChart. I navigated through 40-plus menu items, including the “Sharing Hub,” where I watched videos on Care Everywhere that explained its benefits but not how to restrict its uses. In the end, I found one section under “Authorize Sharing” that said I could “request that your information no longer be shared” by sending a message to customer service. I tried that. I got no response.

Then I tried emailing and calling the hospital system’s ethics and compliance department to opt out of Care Everywhere. Crickets.

After weeks of dead-ends, I found something that worked. When I called MyChart’s patient support number, the representative said I could opt out by contacting the hospital’s medical records department. I called medical records, and they called back that day and confirmed I was opted out of Care Everywhere.

But how are patients supposed to know about this process? I couldn’t find “contact medical records” described anywhere in MyChart or on the hospital’s website.

I asked Epic for an interview, and they agreed to let me speak with Matt Doyle, who leads software development for Care Everywhere. Turns out, both of us were about to be in Las Vegas, for one of the largest healthcare tradeshow conferences in the country. I arrived early at the Epic booth, which is well-appointed among its peers in the Exhibition hall with carpets and a private meeting room. Posters proudly announced that health providers exchange approximately 22 million patient records each day through Care Everywhere.

Doyle walked over from a hub of Epic employees clicking through MyChart screens with conference attendees, and led me to the meeting room along with a colleague from public relations.

“So when you check in for your appointment, the de facto position is you’re part of Care Everywhere,” Doyle confirmed, “unless you explicitly opt out.” 

I recount for him everything I tried, and how there was nothing I could click in MyChart to opt out.

“It’s not in the MyChart enrollment process,” Doyle clarified, “but as soon as your MyChart account is set up, you can immediately go opt out.”

Doyle explained that there are two levels of opting out. 

“One is, ‘Revoke authorization, but I still want to be discoverable,’” he said. “And what that would mean is, let’s say today you’re in a car accident. You go to the emergency department. Your doctor’s office back in Ohio doesn’t have your authorization on file, but you’re discoverable.” Meaning, a doctor could see that a specific patient has a health record, and can ask the patient for his or her consent to access that record. 

The second level of opting out is to be completely undiscoverable through Care Everywhere. In this case, doctors who work in other hospital systems can’t see any record of the patient in Care Everywhere. It’s a choice only 112 patients have made since they rolled out the ability to opt out this way in August 2025, Doyle said.

There’s one extra twist. Doyle confirmed that there isn’t a single place to revoke authorization everywhere. “You have to go to each custodian of your medical records,” he clarified. A patient would revoke access to Care Everywhere “with each place that you receive care.”

“Can you show me how to opt out?” I asked. 

Doyle brought me back out to Epic’s booth, where employees have demos of MyChart on multiple screens. Doyle tried to find a demo where he can show me a new, patient-facing feature to revoke authorizations for data sharing. But the patient in the demo product had not signed any authorizations, so there was no way to show me how to revoke them.

I asked the next public relations representative who joined us if I could see it on her MyChart. She pulled it up on her phone, went to the “Sharing Hub” menu options, but we didn’t see the “Revoke authorization” button. We looked at Doyle, who then explained that only organizations that have updated their Epic software would have the opt-out methods that he described. He offered to show me on a video call the following week. 

Until a patient’s healthcare provider updates their software from Epic, Doyle confirmed that a patient’s only option is to call the medical records department and tell them “I would like to opt out of Care Everywhere.”

A week later, three Epic representatives joined my meeting with Doyle to show me how to opt out in the Sharing Hub section of MyChart. 

“There’s two different places,” explained Sean Bina, vice president of access and patient experience at Epic, as he showed me the buttons in MyChart. “One is ‘managing my record authorizations.’ And then the second is how I can prevent other organizations from requesting a record.”

After months of trying, I finally got to see actual buttons inside of MyChart that would let me opt out.

After this interview, Epic did not respond to further questions from CalMatters and The Markup about Care Everywhere, including how many current patients have the ability to see the opt out buttons inside of MyChart.


A prime example of how using health data for profit involves companies that use what expecting parents search for or watch online and what they’ve shopped for, to target them with baby ads.

Mary Ebeling, a sociologist at Drexel University who wrote the book “Healthcare and Big Data,” had just learned in March 2011 that her doctor could no longer detect a heartbeat in her 11th or 12th week of pregnancy. 

“After learning that I lost the pregnancy, literally, I came home, and my mail carrier delivered the first issue of a year’s subscription [of the now-defunct magazine American Baby] for free,” she recalled. “I had not signed up for it — to American Baby. And I was like I’m getting angry right now about it.” 

The unsolicited baby-themed marketing continued, and she eventually discovered that the data broker Experian was selling her information in a database of “new parents.”

Commercially gathered data, such as Ebeling’s online search or purchasing history, doesn’t have the same legal protections as health records at healthcare facilities, which are covered by the Health Insurance Portability and Accountability Act (HIPAA). But that protection isn’t bulletproof. Past Markup investigations have found that HIPAA-covered hospitals were sending sensitive patient data to Facebook through Meta’s tracking pixel.

Federal law also allows confidential substance use disorder treatment records to be shared in certain circumstances, such as with probation officers.

As a part of her work, Jacqueline Seitz, deputy director of health privacy at the Legal Action Center, frequently speaks with patients who use drugs, are in recovery, are living with HIV, and/or are in treatment for substance use disorders. She also regularly speaks with the health providers who treat them.

“When I talk to providers and I ask them what they tell patients, they say, ‘We tell patients everything is confidential.’ And that is not the right thing to say. That is not true,” Seitz said.

For patients who are mandated into treatment in order to maintain their employment, custody access or probation, when asked, their medical records must be shared with probation officers or other legal authorities, Seitz explained. It’s why she increasingly sees electronic health records as a rap sheet.

“I don’t think people are trying to trick patients,” she said, but she regularly sees examples of healthcare workers not fully understanding confidentiality rules in these cases.

Opting out of CliniSync, Ohio’s statewide nonprofit health information exchange

In addition to being asked to sign up for MyChart when I registered for my appointment at the University Hospitals in Westlake, Ohio, I was also asked to acknowledge my participation in CliniSync.

CliniSync, Ohio’s statewide nonprofit health information exchange, facilitates the exchange of patients’ information, like lab results, across institutions. CliniSync is operated by the Ohio Health Information Partnership, an independent private nonprofit founded in 2009. Ohio’s governor designated the partnership to develop the statewide exchange.

The hospital system posts many of its forms online, so I had time to research the General Consent to treatment form in advance. That alerted me to how patients are defaulted into sharing their data with CliniSync. 

A quick online search for “UH privacy policy” (UH stands for University Hospitals) brought me to the hospital system’s HIPAA Notice of Privacy Practices. It says I can opt out of CliniSync if I contact their privacy officer over the phone, and it gives me an email and phone number. I emailed right away. I didn’t hear back before my appointment four days later.

I also know that CliniSync likely has its own policy, separate from the hospital system’s, so I also searched for its opt-out policy online. The instructions are simple but surprised me: CliniSync asks patients to notarize its opt-out form.

“It’s a big time suck for people. They’re going to have to spend a lot of time finding a notary. They’re going to have to pay that notary, almost certainly, unless they happen to have a friend or family member who’s a notary public,” said Lior Strahilevitz, a legal scholar at the University of Chicago who writes about privacy and teaches health law. Not only is requiring a notary burdensome, it’s also legally questionable. General guidance from the federal government states that HIPAA authorizations do not need to be notarized.

Still, I paid the $15 at UPS to get the form notarized and mailed it out.

The Ohio Health Information Partnership, which operates CliniSync, declined to respond to questions about why it requires patients to get their opt-out requests notarized.

Finally, on the day of my appointment, I tried what should have been the easiest method for patients: Asking the hospital to opt-me out in-person.

When I asked the receptionist at my appointment how I could opt out of CliniSync, she said she didn’t know, but she’d run my request up the chain while I was with the doctor. When I came back, she had an answer: Patients can’t opt-out. A colleague at the hospital told her through email that CliniSync “ensures that providers across various hospital organizations are able to request and access patient medical records, as it relates to medical need and treatment. This is not feasible to be ‘removed’ from clinisync.”

CliniSync does, in fact, have a form to let patients opt out. And clinic staff can sign the form so that patients don’t have to find a notary instead. It says so right on the CliniSync opt-out form.

But in my research into how difficult it is for patients to opt out of processes like this, multiple hospital staff have given me inaccurate information. I wasn’t surprised.

Strahilevitz described this as a common problem in any bureaucracy, a phenomenon known as “desk clerk law.” 

“Basically, there’s what the law is, and then there’s what the person at the DMV who’s actually interfacing with the consumer thinks the law is or what the person at the Secretary of State’s office is,” Strahilevitz said. “And so I would regard your experience with the receptionist as a classic instance of desk clerk law.”

University Hospitals declined to respond to questions about whether its patients can opt out of CliniSync, and did not have an expert available for an interview. 

After my appointment, I called the hospital’s compliance office and a few days later, I got a voicemail asking for more information over email, or for me to call them back. Since I know that Ohio law requires requests to opt out be written, I emailed the hospital with what they ask for. When no one responded, I called and emailed again.

Soon after my appointment, I got a hand-addressed letter from CliniSync confirming my opt-out and saying they processed it shortly after they received my notarized letter. I’m pleasantly surprised, because I’ve followed many opt-out processes in the last year, and it’s uncommon to get verification like this.

Two weeks after I saw the doctor, the hospital’s compliance office confirmed my opt-out from CliniSync over email.

Because CliniSync records a patient’s opt-out centrally, one request blocks other providers from seeing a patient’s records through CliniSync’s network, but for many health exchanges, including Epic’s Care Everywhere, patients would have to discover and follow an opt-out process at each new provider. 

Sweeney, who was the chief privacy officer and general counsel at a company that supported health exchanges in more than 10 states, estimated that a typical patient might have to opt out of data-sharing at as many as 10 different places — wherever they seek care — for their opt-out to be meaningful. 

In most states, she said, “the place to cut off the data exchange is at the provider because that’s where it starts.” 

In some rare cases, patients do not need to go through this complicated opt-out process, because their clinic refuses to share any patient data with health databases or platforms, simply because patients haven’t explicitly consented.

Dr. Keith Smith runs the Surgery Center of Oklahoma, which markets transparent pricing and cash payment. The center does not accept insurance or Medicare, and it has tried to refuse government agencies’ requests for patient data, such as from the state health department. 

“There’s no shortage of people that will claim that they have a legal right to see how many patients operated on at Surgery Center of Oklahoma had breast cancer or had inguinal hernia repairs,” he said. “And the patients haven’t consented to the release of their records.”

Because Smith’s surgery center does not accept federal dollars, he isn’t obligated to report as much information to the government. “We treat patients here as individuals. And I don’t think it’s right to violate the rights of an individual for the greater good,” he said. “All the individual cares about is that their rights have been violated.”

Refusing to let the hospital own my photos, videos or recordings

In addition to asking me to share my patient records with multiple health exchanges in order to see my doctor, University Hospitals also required me to give it complete ownership over any photos, audio or videos it takes of me. Its consent form states, “UH may, unless otherwise refused, photograph and/or audio or video record me or the Services I receive, including those in which I am identifiable. UH will own such images or recordings and may use them for any lawful purpose.”

I have rarely pondered the possibilities: If the doctor takes a picture of a rash on my child’s body for diagnostic purposes, would I want the hospital to claim ownership over or have broad rights to use that photo?

The consent form says I can refuse, but when I asked the hospital’s compliance and ethics office, they wouldn’t let me. 

“…we are not able to accept modifications or partial withdrawals of specific provisions within the General Consent for Treatment itself,” said the hospital’s email. “This includes provisions related to incidental recording that may occur as part of delivering or documenting care.”

That surprised me. In hospital systems, the compliance office is usually where staff have privacy expertise. The hospital refused to follow its own policy.

University Hospitals declined to respond to questions about whether its patients can refuse giving the hospital ownership over images and recordings it takes of patients.

“It’s misrepresentation,” said Strahilevitz, the University of Chicago expert. “So I think that’s just fraud to tell you you have a right and then telling you, ‘No, we were wrong. You don’t, in fact, have that right. And now your photograph and/or audio and/or video is going to be used.’”

Fischer, who refused to see a speech pathologist because the doctor’s office insisted on a right to record her child’s lisp treatment, said she sees health providers requiring parents to agree to clauses like this all the time.

“I can’t get a link to telehealth appointments for my kids without signing agreements that include things like ‘authorize the use of photos, videos, and/or recordings’ and ‘give permission for staff (including students) to participate and/or watch for training purposes’ or other things I don’t want to agree to,” she said. “But there is no option to not sign.”

Experts say there are practical design and regulatory solutions

Colin Gray, an assistant professor at Indiana University Bloomington and a leading expert on manipulative designs said, “You start from the position of defeat rather than starting from the position where you’re making a rational choice … the attitude is, ‘Well, if you really cared about your data, then you would go through the extra steps to turn it off.’ And in this case, it’s like, ‘That’s an hour of my time or 26 steps or whatever it is that I don’t have.’ And so it looks so onerous from the beginning, like, why would you even try?”

Experts like Stacey Tovino, a professor who teaches HIPAA privacy law at the University of Oklahoma College of Law, say there’s a clear and practical solution: “Amend these [federal] regulations to say covered entities shall not impose an undue burden on people trying to opt out.” Tovino suggested that when patients see that they can opt out in a form, the next sentence should include a link to do so.

Some states have laws that require this type of solution. Under New York law, for example, providers need explicit consent from patients to access their data from health information exchanges. I saw it firsthand when I registered my son for an appointment in upstate New York. The check-in screens showed me a form labelled “Health Exchange,” and asked for my consent for the physician group to access all of the patient’s medical records through Healthix, a health exchange. When I clicked “No,” the next form showed the detailed consent form with “I DENY CONSENT” selected as one of my two choices. But when a provider in Virginia, which doesn’t have a state law with explicit opt-in or opt-out requirements, informed me I had the choice to opt out, it refused to let me. My only option was to click “I accept” and to follow an opt-out process after the fact. 

According to Seitz, the health privacy director who works with patients going through mandated treatment, one major challenge in privacy law is that it’s difficult to put a dollar amount on the type of harm people experience, such as when intimate details about their lives are stored in recorded therapy sessions on an unsecured database, like Confidant Health did in 2024. Individuals can’t file a civil lawsuit or sue their doctor for violating HIPAA, which means that only the federal government or state attorney generals can enforce it. As a result, Seitz said that the attitude in healthcare around data breaches is: “Yeah, I’m breaking the law. What are you going to do about it?” 

To make privacy violations actionable, Seitz said, “I would want statutory damages. Like, every corporate defense attorney’s nightmare where it says, ‘Every breach equals $2,000,’ and then all the client has to do is show the breach, and then it’s money.”

At the end of the day, experts said one of the most important parts of the health data ecosystem is trust.

“Every single health data custodian that exists should be doing everything that we can to nurture and protect and foster the trust of those whose data we protect,” said Schmit, the health law and policy professor who wrote about how health exchanges can benefit the public. “And one thing that will absolutely undermine that trust are structures and processes that are opaque and difficult to follow, that make patients feel like they aren’t cared for.”

Patients: All my best tips on how to opt out of data sharing

Even when patients are told they can opt out, medical providers often don’t give patients instructions on how. For patients who are interested in opting out, here are my best tips on how to start.

Illustration of a patient standing in the middle of a maze which spells out the words “opt out”; there are multiple signs pointing to different directions with written phrases like “call compliance,” “contact medical records,” “visit notary,” and “mail letter”
Illustration by Gabriel Hongsdusit, CalMatters

CalMatters and The Markup’s reporting has found that opting out of data sharing is much more difficult than it needs to be because deceptive designs or “dark patterns” make it more work to say no than to say yes. Research has found that when given the choice, people prefer to have more fine-grained control over how their medical data is shared or used. 

In the last year, I registered as a patient at 25 clinics and hospitals across seven states and spent hundreds of hours reviewing consent forms, privacy policies and marketing forms to see whether I could actually opt out of sharing my data. Sometimes, opting out was simple. Other times — like in our most recent reporting on MyChart and University Hospitals in Ohio — the process was extremely convoluted. 

For patients that are interested in opting out, here are my best tips to get started: 

  1. Get the forms in advance. A provider’s office will often send you a link 24 to 48 hours in advance of your appointment. Sometimes, you can download them off a hospital website. I usually search online for keywords like “consent forms + hospital name.” Getting the forms early means you can take many of the steps below at home, instead of under time pressure immediately before your appointment.
  2. Nice to have: Keep a dedicated phone number and email address for health visits. It’s not always possible, but if you can, get a dedicated phone number such as through Google Voice’s free plan or the paid Burner app. Set up a new email inbox just for healthcare appointments, such as with Gmail or Proton Mail. When filling out contact information for appointments or creating a patient portal account, use your dedicated phone number and email address. This step makes it easier for you to track all the forms health providers send you, and potentially, to track your data trail in the future.
  3. Use the screen recorder already installed on your phone, computer or tablet to record your screen as you read through the forms, so you have a copy of what you sign. Here are instructions for iPhones and tablets and Android devices. On a Mac computer, press Command + Shift + 5 and select the Record button (looks like a bullseye).
  4. Read or skim for specific terms like opt-out, withdraw consent, restrict, refuse, responsibility, optional, authorization.
  5. Read or skim the privacy policy for clues about what instructions to follow to opt out. Every healthcare provider should have a privacy policy. Sometimes, a privacy policy will give you the email address or phone number of who to contact to opt out of sharing your data. You can contact them ahead of your appointment to try and opt out.
  6. Arrive early to your appointment. Like 45 minutes early. Politely request paper forms. On paper workflows, you can skip ahead without being forced to engage with voluntary forms that are bundled in with required forms. Many privacy-conscious patients also try to cross out terms they disagree with, which they date and initial. But keep in mind, some forms explicitly note that changes to those forms are not binding.
  7. Take photos or videos of the forms you sign. And when you return the forms to a receptionist, politely ask them to provide you with a photocopy of your signed and completed forms. Keeping your own records is important, and sometimes obtaining them later can be a kafkaesque process.
  8. If you are struggling to get a copy of a form you filled out, or if there are terms you’d like to opt out of but you can’t figure out how, try politely asking the front desk or a provider how to proceed. If they do not know, try the following:
  9. If none of the above works, one more place you can try is the “medical records” department at many hospitals. That work may be outsourced to another company. Get the name and contact of the department or the company by asking at an information desk. Then ask the medical records contact how you can opt-out.
  10. Email me if you get stuck, or have questions. I might not know the answer, but I might be able to help you strategize to get it. Or, if you figure something out that unlocks an opt-out, I’d be glad to hear about it! arosenblat@themarkup.org
  11. If you think your rights have been violated, submit a complaint to the Office for Civil Rights at the U.S. Department of Health and Human Services. Peter Swire, the White House coordinator for the HIPAA privacy rule under President Bill Clinton, recommends involving HIPAA enforcers to weigh in on practices. “You can bring complaints when you’re only 80% sure. A complaint is a complaint. Then, they're supposed to look at it with their expertise,” he said. HHS can issue guidance or address enforcement concerns through their FAQ page in response.

Building A UX ROI Case That Survives The Boardroom

Sooner or later, a CFO looks at your wireframes and asks what any of it actually does for the bottom line. Storyboards don’t answer that question, and the era when a 5-minute pitch could answer it ended, unfortunately, a while ago.

These days, if you want to win budget, buy-in, and backing for UX, the design has to be provably good for the business, not only for the people using it.

And proving that takes more than taping a dollar sign to a redesign. You have to understand how your organization defines value in the first place, how it measures that value, and how a credible line gets drawn between a design initiative and an outcome leadership already cares about.

Rather than scatter tips, this article follows one worked example the whole way through. Meridian is a mid-size B2B SaaS company, and it is entirely made up — that label matters, so it gets repeated where it counts. Its onboarding redesign carries the same figures from goal-setting through cost accounting, causal testing, and the final ROI number, because a framework only becomes tangible when the numbers connect. Every step is one you can rerun inside your own organization.

Why ROI Matters More Than Ever in UX Conversations

Companies now want clarity on what every dollar buys, and “delightful user experiences” stopped clearing that bar some time ago. I still remember a former colleague celebrating a $1 million redesign he’d gotten greenlit mostly on the strength of a couple of three.js tricks. Try that pitch in front of a finance team today and see how far the particles get you.

Executives don’t hate UX, they just hate vagueness. A pitch built on “users will find it easier” loses, every time, to the department promising 12% more sales in Q3. The difference is the one between a streamlined checkout flow that reduced cart abandonment with completed purchases up 22%, and the same work rewarded with “the QA testers like it.” One of those goes on your resume. The rest of this article is about earning the first version, with Meridian’s numbers doing the work.

When Business Goals And KPIs Don’t Exist Yet

Most writing about UX ROI makes a convenient assumption: that the organization already owns clean business goals and KPIs for you to hook your work onto. Real companies are messier than that. Plenty run on ambitions like “grow faster” or “improve the customer journey” that nobody ever broke into anything measurable, and an ROI case built on that ambiguity sounds impressive right up until somebody scrutinizes it.

So the first job is often to help the organization define what success even looks like. Interview stakeholders across departments — what does product consider a good quarter, where does customer success watch users struggle, where do sales deals stall — and listen for the themes that keep resurfacing across conversations, because those recurring themes are the company’s latent business objectives. A useful forcing function is the OKR model (Objectives and Key Results), which doesn’t tolerate vagueness.

At Meridian, the stated ambition was “improve the rate of new users’ adoption of the platform,” which you can neither design toward nor measure against. Interviews turned up the real shape of the problem. Trial users needed a median of 14 days to reach first value, most churned before getting there, and onboarding questions were burying the support queue. Out of that came an OKR with actual edges: reduce median time-to-first-value from 14 days to 7 with the use of a guided setup flow, and lift trial-to-paid conversion from 8% to 9.5%.

One warning about formalizing KPIs: Impose them from inside the UX team and leadership will suspect you’ve rigged the field in your own favor, so co-create them with whoever owns the outcome — though never at the price of accepting targets that set your team up for an uncomfortable situation. Meridian’s head of product agreed that setup-completion rate was a fair proxy for onboarding usability, and customer success signed off on time-to-first-value, a number already sitting on their own dashboard.

A KPI ladder that ends at a metric somebody already watches buys you credibility before any design work starts.
Quantifying The Full Cost Of The Investment

ROI has a denominator, and the denominator is where most UX teams go wrong. You can’t calculate a return without strategic financial planning, yet cost usually gets counted as designer salaries or consulting hours and nothing else. A finance team will find the rest whether or not you counted it, so count it first.

Direct costs are the visible ones. Meridian’s redesign ran $45,000 in design and research labor plus another $8,000 in tooling and participant incentives. Licenses for Figma, UserTesting, Hotjar, analytics platforms, research incentive spend — all of it belongs in the total, and that’s before the inevitable instances of vendor lock-in every UX team eventually faces. Engineering sits in the same column, because a UX redesign doesn’t stop at the mockup. Building the guided setup took two frontend sprints plus a QA pass, $38,000 worth, and the project generated about $4,000 of coordination overhead along the way in new syncs and shared dashboards.

The line item nearly everyone misses, and the one worth stealing from this article if you steal nothing else, is stakeholder time. Workshops, design reviews, and feedback sessions all pull senior people away from their primary work. A VP of Product spending four hours a week in UX reviews is a VP not spending those hours on roadmap planning or partner negotiations. Log the attendance — who came, for how long, at what seniority — and price it at fully loaded cost, meaning salary plus benefits divided by productive hours. A quarter’s worth of workshops, reviews, and interviews at Meridian priced out at $22,000.

Add it all up: $45,000 in design labor, $8,000 in tooling, $38,000 in engineering, $22,000 in stakeholder time, $4,000 in coordination. The investment is $117,000. Saying that number out loud beats saying “we spent $45K on design,” precisely because it already includes everything a finance team would have dug up on its own.

Proving Causation, Not Just Correlation

Most UX ROI pitches die right here. Conversions rose after the redesign, sure — and the CFO wants to know how you ruled out the new pricing, the seasonal traffic bump, and the marketing campaign that shipped the same week. Without a convincing answer, your entire ROI story crumbles.

After all these years, the gold standard for proving causation is still A/B testing: run the old experience against the new one on an even traffic split until the sample means something.

Onboarding happens to suit a phased rollout, which is why Meridian could do this cleanly. For eight weeks, half of new trial signups received the redesigned guided setup while half stayed on the legacy flow. Control converted to paid at 8.0%. The variant came in at 9.4%. With roughly 6,100 trials inside the window, the difference was statistically significant, but a 1.4-point gap on a single test is still the kind of result that deserves a second look before anyone builds a budget on it, which is one reason the team held back on attribution below. Where a split isn’t feasible — a change too structural, a user base too small — fall back to a time series instead. Measure steadily for weeks before the change, implement, then keep measuring against the baseline you established.

Documenting whatever else happens around the same time as your UX change is the unglamorous half of causation.

A pricing-page test from Meridian’s marketing team overlapped weeks five through eight of the rollout. The UX team noted it, confirmed it hit both cohorts evenly, and still chose to attribute only 70% of the observed lift to the redesign in the final math. There is no formula that produces that number; treat it as an illustrative assumption for this example.

The team asked how much of the lift could plausibly belong to the pricing test if it had helped one cohort slightly more than the other, settled on a ceiling of about a third, and rounded the redesign’s share down to 70%. Your figure will differ. What matters is that it is written down and argued for before the results arrive, not fitted to them afterwards. That restraint is worth money in a skeptical room. “We attribute roughly 70% of the lift to the onboarding change, with the remainder likely influenced by concurrent pricing work” survives cross-examination; claiming everything does not. Cohort analysis then backed the number up, since the lift held across acquisition channels and tenure bands, and at that point the skeptics had very little left to work with.

Leading and lagging indicators belong on the same slide, because each covers the other’s weakness. Meridian’s leading indicators moved first — setup completion climbed from 62% to 89%, median time-to-first-value dropped from 14 days to 6.5 — and the lagging trial-to-paid number followed. Mechanism first, business outcome second. Presented together, they form a causal chain that’s harder to poke holes in than either one alone.

The ROI Calculation, End to End

So what did Meridian actually earn? The company sees about 40,000 trial signups a year. Lifting conversion from 8.0% to 9.4% adds roughly 560 paying customers annually, and at an average of $1,800 in annual recurring revenue per account, those customers represent about $1,008,000 in new ARR. Applying the conservative 70% attribution from the causal work trims the defensible figure to roughly $706,000.

Set that against the full $117,000 investment and the first-year ROI lands near 5:1, with payback arriving in roughly two months. There’s a second line, too. Onboarding-related support tickets dropped about 30%, some 3,600 fewer tickets a year, worth another $54,000 annually at $15 per resolved ticket. Keep it as its own line rather than folding it into one swollen headline number. The case reads as more honest that way and loses none of its force.

Three assumptions carry that result, and each belongs on the slide next to it. The 40,000 signups and the $1,800 average ARR are the prior year’s actuals held flat, so a growth or pricing change moves the outcome in either direction. The 70% attribution is the illustrative assumption from the causal work, not a measured quantity. And the two-month payback counts new ARR as it lands rather than revenue recognized net of churn, which flatters the timeline; on a net basis the payback stretches to roughly a quarter. State those three plainly and a finance team can adapt the example to its own numbers. Hide them and the whole thing starts to look like marketing math, however careful the experiment was.

What persuades in the final presentation is not sophistication. Open with the baseline: what stalled trials and support volume were already costing. Show the delta in terms leadership reads fluently, metrics like conversion rate uplift chief among them. A chart of setup completion climbing from 62% to 89% will beat a paragraph of UX jargon, and a translation like “each abandoned setup costs us 0.3 support tickets” beats the chart. Above all, keep every figure identical from the first slide to the last. A room full of finance people forgives many things, but never numbers that wobble between slides.

Tailoring The Case To Whoever Holds The Purse Strings

Budget decisions come out of coalitions. A CFO may hold the final say when adding AI to the checkout process, but marketing, product, and customer success all lean on that decision, and each means something different by “value.”

A CFO hears cost, revenue, and risk. A CMO hears conversion and acquisition cost, since UX is a lever for increasing marketing ROI. Product counts support tickets; customer success thinks in retention. The underlying numbers never change; only the framing rotates, and a CFO wants a projection, not a moodboard. Meridian’s CFO slide read “the onboarding redesign protects roughly $706,000 in new ARR a year against a $117,000 investment,” while the CMO version led with what a 9.4% trial conversion does to blended acquisition cost.

Beyond the Dollar Sign: Qualitative and Non-Financial Metrics

Some UX outcomes never translate cleanly into revenue, and pretending they do weakens the parts of your case that are solid.

The trick with qualitative evidence is collecting it rigorously enough that nobody can wave it off as anecdote.

Scores like Net Promoter Score (NPS), CSAT, and Customer Effort Score already sit inside most reporting cadences, which makes them cheap to borrow. Tie your work to their movement, and segment wherever the data allows.

Meridian could say that NPS among trial users on the redesigned onboarding was 51 against 34 for the legacy flow, which lands far harder than any blended average. Verbatim feedback from surveys, support transcripts, and app store reviews adds the emotional weight the scores lack. Internal tools deserve the same discipline, since employee experience is increasingly recognized as a business driver — a dashboard redesign that hands account managers 45 minutes a day back is a productivity gain, a satisfaction gain, and a retention lever all in one.

Brand perception resists direct measurement but leaves tracks in repeat visits, organic referrals, and social sentiment. It carries extra weight in trust-sensitive industries like finance or healthcare, and it forms fast, given that UX design influences the first impressions of a whopping 94% of customers.

Whatever you collect, systematize the collecting. Run pre- and post-surveys with consistent question sets, use structured usability testing with task-based scoring, and put the qualitative right next to the quantitative when you present.

“Setup completion rose from 62% to 89%, and in post-test interviews 8 of 10 participants called the new flow intuitive, against 3 of 10 for the old one” — a pairing like that is much harder to dismiss than either half on its own.
Making the Case Stick

UX loses the budget battle unless it’s mapped to company-wide objectives, so phrase the proposal in the words of this year’s board presentation.

Nobody at Meridian pitched “simplify the onboarding UI”; the pitch was a redesigned trial experience worth 1.4 points of upgrade rate, roughly $1M in annual recurring revenue before attribution. Bring evidence in both registers, since that is what social proof is for: the case, clearly labeled, plus screenshots, impact graphs, and user quotes. Find internal allies who can repeat the ROI narrative in rooms you’ll never enter, and write the playbook down, because repeatable ROI is what earns recurring investment.

Resources for Going Deeper

This topic has been explored extensively by researchers, practitioners, and consultancies. Here’s a curated set of resources worth studying if you want to build a stronger ROI practice around UX.

  • “Measuring the User Experience” by Tom Tullis and Bill Albert is the definitive guide to UX metrics. It covers everything from task-based measurements to survey design to statistical analysis, and it’s written for practitioners, not academics.
  • Jared Spool’s “The $300 Million Button” case study is a classic example of how a single UX change (removing a mandatory registration step) generated massive revenue uplift. It’s a story every UX professional should have in their back pocket.
  • Forrester’s research on UX ROI provides enterprise-focused frameworks for building business cases around experience design, including their widely cited finding that every dollar invested in UX returns $100.
  • “UX Strategy” by Jaime Levy bridges the gap between design thinking and business strategy, offering practical tools for aligning UX initiatives with organizational goals and market positioning.
  • The Design Value Index by the Design Management Institute tracks publicly traded companies that invest heavily in design against the S&P 500. The data consistently shows that design-led companies outperform the index by significant margins, and it’s a powerful data point for executive presentations.
  • Google’s HEART framework provides a structured approach to selecting UX metrics at scale. HEART stands for Happiness, Engagement, Adoption, Retention, and Task success, and it’s particularly useful for teams that struggle to decide which metrics to track.
Conclusion

A seat at the table never comes from beauty or novelty. It comes from measurable, defensible impact, which means UX leaders have to trade the artist’s posture for the strategist’s. Speak in outcomes rather than outputs. Connect pixels to profit.

When someone challenges the numbers, don’t flinch. Show the controlled experiment, the cohort analysis, and the before-and-after metrics, every figure holding steady from the first slide to the last, the way Meridian’s did, with the customer quotes and the employee-satisfaction data sitting right beside the revenue impact. Prove the work does more than delight users, and be ready to defend the ratio line by line. That’s when the CFO leans in, and that’s when design stops being optional.

❌